Bristol-Myers Squibb to Hold Investor Webcast to Discuss ASH Highlights

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will hold an investor webcast on Sunday, December 8, 2019 at 8:00 p.m. ET to discuss data presented at the American Society of Hematology meeting, in Orlando. Company executives will provide an overview of data presented and address questions from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the event at investor.bms.com. Materials related to the event will be available at the same website prior to the event. A replay of the event will be available and can be accessed at investor.bms.com.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191126005162/en/

Media:
[email protected]
609-252-3345

Investors:
Tim Power, 609-252-7509, [email protected]
Nina Goworek, 908-673-9711, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Hunting PLC (“Hunting” or “the Company” or “the Group”) Results for the Six Months Ended 30 June 2026
• Hafnia’s Q2 2026 Financial Results Presentation to Be Held on 28 August 2026
• UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)